American Senior Communities, the largest nursing home company in Indiana, has agreed to the settlement to resolve allegations that it violated federal laws by submitting false claims to the Medicare program.
Read More
The fines are one way Medicare is clamping down on hospitals, using penalties and incentives authorized by the Affordable Care Act to push for better outcomes, fewer safety problems and a lower number of readmissions.
Read More
The FDA has agreed to speed up review of donanemab, but the Centers for Medicare and Medicaid Services is moving to limit reimbursement for drugs in this class to only patients in clinical trials.
Read More
In Indiana last year, dozens of insurers across the state rolled out plans hoping to get a sizable piece of the fast-growing market.
Read More
At stake are billions of dollars in bonuses that the Centers for Medicare and Medicaid Services awards to insurers that achieve a certain start rating on their Medicare Advantage scores.
Last month, the federal Medicare program proposed a 2.9% cut to physician pay for 2025. That marked the fifth straight year that regulators proposed cutting payments to doctors for thousands of services, from stitching a wound to replacing a knee.
Some of America’s seniors will see their out of pocket costs fall for more than five dozen drugs—including treatments for osteoporosis and cancer—as part of the White House’s crackdown on rising pharmaceutical prices.
An improving economy has contributed to changed projected depletion dates, according to the annual Social Security and Medicare trustees report Monday. Still, officials warned that policy changes are needed lest the programs become unable to pay full benefits to retiring Americans.
Rarely a day goes without President Joe Biden mentioning insulin prices and promoting a $35 price cap for the medication for Americans on Medicare. The reality is more complicated.
Obesity drugs like Wegovy and Eli Lilly’s Zepbound are showing promising results in helping people shed pounds. But a law bans Medicare from paying for weight loss drugs. Now, drugmakers and a bipartisan coalition of lawmakers are gearing up to push for that to change next year.
If history is any guide, there will be plenty of high-budget television ads from national and local insurance plans looking to boost their rolls. But the Centers for Medicare & Medicaid Services is cracking down on misleading pitches.
The Biden administration is targeting diabetes treatment Jardiance and nine other medications for Medicare’s first-ever drug price negotiations as it seeks to lower medical costs for Americans.
David Ricks, CEO of Indianapolis-based drugmaker Eli Lilly and Co., is turning up the volume on his concerns over a new law that would allow Medicare, for the first time, to negotiate drug prices.
The proposed hike would likely increase tax revenues by more than $117 billion over 10 years, according to estimates by the Tax Policy Center.
A slew of health care bills moving through the legislature target high prices for Hoosiers by encouraging competition and restructuring how the state pays for services under Medicaid.
Federal watchdogs have been sounding the alarm for years about questionable charges on the private version of the Medicare program, with investigators raising the possibility that insurance companies may be bilking taxpayers of billions of dollars every year.
The fast-growing, family-owned operation, based in Miami, has filed plans with the state to renovate three buildings and open them as primary care medical clinics.
The number is down from 62 hospitals last year and 66 the before, but will still cost many hospitals money while they are still dealing with the strain of the pandemic that has overwhelmed resources and reduced their revenue and profits.
Health care can be expensive, so picking the right insurance plan that meets your individual or family needs can be critical to maintaining a balanced budget.
Under the latest proposal, people earning more than $400,000 a year and couples making more than $500,000 would have to pay a 3.8% tax on their earnings from tax-advantaged businesses called pass throughs.
A new study released Thursday by the Rand Corp. showed that Hoosiers covered by employer health plans paid Indiana hospitals nearly three times—or 292%—of what Medicare would have paid for the same procedures.
Prevounce Health, which launched in 2019 in Los Angeles, relocated its operations to Indianapolis last fall and just landed $4.5 million in investment funding which the company says will help it expand and double its workforce in coming months.
The push by Eli Lilly and Co. will come despite an unfavorable ruling last week from Medicare that sharply restricts reimbursements for a drug in the same class.
Thursday’s coverage decision illustrates the impact that a single medication can have on the budgets of individuals and taxpayers.
